Back to Search Start Over

Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus

Authors :
C. Intrivici
Nicola Gebbia
F Aragona
Antonio Russo
Valentina Agnese
Daniela Cabibi
Gianni Pantuso
Eugenio Fiorentino
Donatella Calcara
Marianna Terrasi
V. Bazan
Giuseppe Colucci
AGNESE, V
CABIBI, D
CALCARA, D
TERRASI, M
PANTUSO, G
FIORENTINO, E
INTRIVICI, C
COLUCCI, G
ARAGONA, F
GEBBIA, N
BAZAN, V
RUSSO, A
Publication Year :
2007

Abstract

BACKGROUND: The development of oesophageal adenocarcinoma is generally closely associated with the presence of a specialised intestinal-type epithelium such as that found in Barrett's oesophagus (BO). A particular histological condition is when the distal oesophagus showing cardiac and/or fundic mucosa without intestinal metaplasia cannot be defined as 'Barrett's mucosa' [condition that we call 'columnar-lined oesophagus' (CLO)] and up till now, there has been no agreement in literature about the management of this condition. Aurora-A overexpression leads to centrosome amplification, chromosomal instability and aneuploidy in mammalian cells. PATIENTS AND METHODS: A prospective study was carried out on 28 consecutive patients who presented columnar mucosa above the gastro-oesophageal junction (GOJ) at endoscopy. As controls, two more biopsies were obtained, one on the normal-appearing squamous oesophagus above the GOJ, as far as possible from the columnar mucosa (controls A), and one taken 1 cm below the GOJ (controls B). The Aurora-A and p53 expression levels were analysed respectively by Quantitative Real Time PCR and immunohistochemistry. RESULTS: Twelve patients were affected by BO (43%) while the other 16 patients (57%) had a CLO. Nine of 28 (32%) cases were focally positive for p53 immunostaining. All the BO/CLO samples were positive for the Aurora-A transcript with regard to controls. Furthermore, 13 of 28 (46%) cases showed overexpression (above the median for the whole group). CONCLUSION: Due to the low number of cases, we are not at present able to state that statistically significant quantitative differences in Aurora-A messenger RNA expression exist between CLO and BO cases with and without dysplasia and p53-positive immunostaining. Further studies on a larger number of cases with a follow-up period are necessary in order to establish the risk of progression and the correct management of these subjects.

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....9071579990045b479306934097a192c6